Gland Pharma Ltd. - Research Center
543245 GLAND Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 1,012.02 | 1,174.83 | 1,097.86 | 1,010.67 | 884.07 |
| Operating profit | 293.55 | 432.83 | 369.49 | 347.10 | 259.36 |
| Interest | 0.91 | 4.53 | 0.80 | 0.91 | 1.60 |
| Gross profit | 341.13 | 475.25 | 412.08 | 387.30 | 292.97 |
| EPS (Rs) | 13.53 | 19.51 | 16.81 | 15.64 | 11.39 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 48.49 | 46.96 | 43.39 | 41.11 | 35.21 |
| Stock adjustment | 104.26 | 26.97 | 103.70 | -22.74 | -20.49 |
| Raw material | 367.69 | 482.88 | 378.43 | 456.63 | 391.80 |
| Power and fuel | 29.42 | 28.91 | 28.62 | - | - |
| Employee expenses | 107.68 | 107.87 | 99.29 | 99.88 | 102.91 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 109.43 | 95.38 | 118.34 | 129.80 | 150.49 |
| Provisions made | - | - | - | - | - |
| Depreciation | 40.82 | 42.56 | 40.33 | 40.24 | 38.98 |
| Taxation | 77.39 | 111.28 | 94.95 | 89.54 | 66.41 |
| Net profit / loss | 222.92 | 321.41 | 276.81 | 257.53 | 187.58 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 16.48 | 16.47 | 16.47 | 16.47 | 16.47 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 29.01 | 36.84 | 33.66 | 34.34 | 29.34 |
| GPM (%) | 32.17 | 38.90 | 36.11 | 36.82 | 31.87 |
| NPM (%) | 21.02 | 26.31 | 24.25 | 24.48 | 20.41 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis